Symbols

Myriad Genetics (MYGN) Plunges 1.88% After Guggenheim Downgrade

Generated by AI AgentAinvest Movers Radar

Wednesday, Apr 23, 2025 6:26 pm ET1min read

Myriad Genetics (MYGN) shares fell 1.88% today, reaching their lowest level since September 1998, with an intraday decline of 2.15%.

Guggenheim recently downgraded Myriad GeneticsMYGN-- from a "buy" rating to a "neutral" rating in a research report released on April 11, 2025. This change in rating is likely to have contributed to the recent decline in the company's stock price. The downgrade suggests that analysts at Guggenheim may have concerns about the company's future prospects or its ability to meet market expectations.

Ainvest Movers Radar

Conocer el mercado de valores en un instante.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments

﻿

Add a public comment...

No comments yet

AInvest
PRO

Editorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process. While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context. Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue